CONCLUSION While some health care challenges and their potential solutions polarize stakeholders and policymakers and thus are never overcome, there are others where consensus emerges and a problem once perceived as unconquerable is solved. Based on our conversations with experts from different parts of the health care ecosystem and levels of government, we believe that Medicaid coverage for cell and gene therapies, especially those for rare conditions, carries the potential to become one of those areas where consensus on the challenges and solutions could develop. The challenges surrounding this issue are significant. However, according to the experts interviewed, so are the consequences of failing to work together to find and implement solutions. Consideration and pursuit of the recommendations detailed above (and others that will emerge) could enable these challenges to be overcome, thus ensuring timely access to 21st-century treatments and cures for patients in the Medicaid program.
34
